Dec 19, 2024 · “Steroid-refractory acute graft-versus-host disease can have significant, wide-ranging health consequences, including damage to multiple organs, reduced quality of life and risk of death in affected patients,” said Nicole Verdun, director of …

Oct 29, 2024 · UK-based private biotech company Ottimo Pharma has emerged from stealth mode after four years with the appointment of a strong leadership team.

Aug 8, 2024 · In its financial report for the second quarter of 2024, Amgen has announced that the FDA has granted Tezspire (tezepelumab-ekko) a breakthrough therapy designation as an add-on maintenance treatment for patients with moderate to very severe COPD with a high blood count of a type of white blood cells called eosinophils.

3 days ago · News on the biopharmaceutical manufacturing industry, focusing on biologics, technology, upstream/downstream processing, cell culture and regulations

Jun 6, 2024 · Nucleus RadioPharma, a leading player in the development, manufacturing, and supply chain management of radiopharmaceuticals, has announced a significant milestone with the closing of a Series A extension round, featuring a new investment from AstraZeneca.

Nov 12, 2024 · AbbVie acquired Cerevel Therapeutics and the rights to emraclidine in a US$8.7 billion deal announced in December last year.. When AbbVie acquired Cerevel, emraclidine was in the process of being tested in two phase 2 trials called EMPOWER-1 and EMPOWER-2.

Oct 22, 2024 · Last year, Thermo Fisher Scientific launched a new mass spectrometer with high resolution and speed, designed to accelerate the discovery of new proteins and advance precision medicine.

Apr 1, 2020 · In the one of the largest deals seen in the contract development and manufacturing organization (CDMO) sector, Danaher Corporation decided to spend $21.4bn (€19.5bn) to acquire GE Healthcare Life Sciences.. Now, with the deal complete, GE Healthcare Life Sciences has emerged at the other side rebranded as Cytiva.

Oct 8, 2024 · But what does the Act mean for the biotech and pharma industry and how can companies best prepare for any impacts on future business? The Biosecure Act was first proposed by the US government late last year due to concerns about national security and how genetic and other biological data could be misused by foreign adversarial governments with a focus on China.

Mar 25, 2024 · The recent submission of clinical trial data for Sanofi/Regeneron’s Dupixent and Verona’s Ensifentrine to the U.S. FDA indicates the entry of new therapies for chronic obstructive pulmonary disease (COPD) in 2024.